
Surgical Microscope Equipment Research and Production Manufacturer
Source: Wabei.com
Wabei.com, September 16 — EDER Medical (839056) announced that the Board of Directors received a resignation letter from Director Chen Fei on September 16, 2021, with the resignation taking effect on the same day. The aforementioned individual holds 0 shares of the company, accounting for 0% of the total share capital. The individual is not subject to joint disciplinary measures for dishonesty and will not hold any other positions within the company following the resignation.
The announcement states that, due to personal reasons, the applicant has tendered resignation from the position of director of the Company. This resignation will not cause the number of members of the Company's Board of Directors to fall below the statutory minimum, nor will it cause the number of members of the Company's Supervisory Board to fall below the statutory minimum, or result in the number of employee representative supervisors being less than one-third of the total members of the Supervisory Board.
Chen Fei's resignation will not have any adverse impact on the company's production and operations.
According to data from Wabei Network, EDER Medical is driven by high and new technology, integrating electronic control with mechanical design. In line with the development trends of the big health industry, the company currently features two major product categories: 1. Surgical microscopes for minimally invasive surgery, with products covering ophthalmology, neurosurgery and spinal surgery, orthopedics, otorhinolaryngology (ENT), and other fields, as well as peripheral supporting systems for microsurgery. 2. "Ocular contact lens" products in ophthalmic optometry, including intraocular lenses and scleral lenses, among others. In the first half of 2021, the company's net profit attributable to shareholders of the listed company was RMB -7,254,104.76, compared to RMB -1,297,878.72 in the same period of the previous year, indicating a year-on-year increase in losses.